Staggered Schedule May Not Harm Firefighter Sleep, Nicole Bowles, PhD, Says
HCPLive spoke with Bowles at SLEEP 2025 on the staggered schedule, referred to as 1/3/2/3, and how it impacts firefighters’ sleep.
Related Articles
Depression Linked to Poor Cardiovascular Outcomes in Spontaneous Coronary Artery Dissection
Patients with SCAD and comorbid depression had greater rates of heart failure, cerebrovascular disease, acute kidney injury, and atrial fibrillation.
19 Trial Meta-Analysis Finds GLP-1 RAs Have Substantial Kidney Benefits
A recent meta-analysis reveals GLP-1 RAs significantly reduce adverse kidney outcomes, highlighting their potential in chronic kidney disease management.
The Future of Obesity Treatment with Martha Gulati, MD
Gulati covers the promises and pitfalls of the healthcare world’s increasing focus on obesity as a disease and the variety of complications to which it…
FDA Approves Prednisolone Acetate Ophthalmic Suspension for Ocular Inflammation
Parent company Amneal Pharmaceuticals, Inc. has announced intentions to launch the topical anti-inflammatory agent in the third quarter of 2025.
Higher Dose Pegloticase Q4W Feasible for Uncontrolled Gout
The findings are the latest from a series of trials seeking to decrease treatment burden for patients with uncontrolled gout.
Long-Term Sotatercept Data Support Durability for PAH, with Ioana Preston, MD
Preston describes lasting unmet needs in pulmonary arterial hypertension and reviews new pooled data supporting sotatercept’s long-term safety and efficacy.
Complex Cases in Atopic Dermatitis and Hair Loss, with Tiffany Mayo, MD
In this Q&A interview at RAD 2025, Tiffany Mayo, MD, highlights the biggest takeaways from her talk on complex cases in atopic dermatitis and hair…
Kidney Compass: Sibeprenlimab and the VISIONARY Trial, with Vlado Perkovic, MBBS, PhD, at ERA 2025
Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.
Upadacitinib Safe for Up to 6 Years for Atopic Dermatitis, Regardless of Smoking History
These data suggest that smoking history did not impact rates of malignancy, MACE, and VTE among those with atopic dermatitis treated with upadacitinib.
Complex Cases in Atopic Dermatitis and Hair Loss, with Tiffany Mayo, MD
In this Q&A interview at RAD 2025, Tiffany Mayo, MD, highlights the biggest takeaways from her talk on complex cases in atopic dermatitis and hair…